$JNJ Company News
Billionaire Stan Druckenmiller's recent moves 11:50 a.m. Feb. 24, 2014 - Insider Monkey
You'd have to be a dope to buy marijuana stocks 1:36 p.m. Feb. 13, 2014 - blogs.marketwatch.com
FDA approval of leukemia treatment boosts shares of Pharmacyclics 1:57 p.m. Feb. 12, 2014 - blogs.marketwatch.com
Goldman: The 4 biggest themes of earnings season 8:06 a.m. Feb. 12, 2014 - blogs.marketwatch.com
10 stocks to beat a declining market 3:01 p.m. Feb. 7, 2014 - Mark Hulbert
Feds, pharma rivals team up on Alzheimer's 2:32 p.m. Feb. 6, 2014 - blogs.marketwatch.com
CVS move won’t slow e-cigarette sales 4:42 p.m. Feb. 5, 2014 - Jonnelle Marte
Newscast: Stocks mixed to start short week 6:32 p.m. Jan. 21, 2014 - MarketWatch
U.S. stocks close higher; earnings misses drag on Dow 4:51 p.m. Jan. 21, 2014 - Anora Mahmudova
Newscast: Stocks open week mixed 4:32 p.m. Jan. 21, 2014 - MarketWatch
Nasdaq nabs 13-year high, but Dow slips: stock market live blog recap 4:05 p.m. Jan. 21, 2014 - blogs.marketwatch.com
Ken Fisher's new top stock picks 2:48 p.m. Jan. 21, 2014 - Insider Monkey
Johnson & Johnson shares take a hit on full-year outlook 11:27 a.m. Jan. 21, 2014 - blogs.marketwatch.com
Newscast: Demand soars for humanely-raised pork 10:00 a.m. Jan. 21, 2014 - MarketWatch
Johnson & Johnson’s profit jumps 37% 9:49 a.m. Jan. 21, 2014 - Tess Stynes
Stock futures rise after China’s cash injections 9:32 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson sees 2014 EPS of $5.75 to $5.85 7:51 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 EPS excluding items $1.24 7:50 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 sales up 4.5% to $18.4B 7:49 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 EPS $1.23 vs. 91 cents 7:48 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Why You Should Consider Guns, Germs And Steel For Your Portfolio 1:04 p.m. Feb. 27, 2014 - Seeking Alpha
Google's Plan For Your Body And Its Stock Split 12:05 p.m. Feb. 27, 2014 - Seeking Alpha
9 Dogs Of The Dow Seek 10% To 17% February Upsides 11:46 a.m. Feb. 27, 2014 - Seeking Alpha
Abbott Labs Has Fallen and It Can't Get Up 6:00 a.m. Feb. 27, 2014 - TheStreet.com
10-K: PHARMACYCLICS INC 5:15 p.m. Feb. 26, 2014 - Edgar Online - (EDG = 10Q, 10K)
Anika Arthritis Drug Approval Sends Stock Soaring 10:47 a.m. Feb. 26, 2014 - Investors Business Daily
Risk And Reward Analysis Of Apple's Stock 10:36 a.m. Feb. 26, 2014 - Seeking Alpha
Are High-Yield Equities Riskier Than Dividend Growth Stocks? 9:43 a.m. Feb. 26, 2014 - Seeking Alpha
Anika Arthritis Treatment Approval Brings All-Time Highs, Maybe More to Come 9:16 a.m. Feb. 26, 2014 - 247WallSt.com
3 Megacap Blue Chips You Don’t Want to Buy 7:47 a.m. Feb. 26, 2014 - InvestorPlace.com
Anika's Osteoarthritis Treatment Wins FDA Approval 5:45 p.m. Feb. 25, 2014 - WSJ.com
3 Dividend Stocks For Retirement 4:57 p.m. Feb. 25, 2014 - Seeking Alpha
Target's Valuation Largely Hits the Mark 4:12 p.m. Feb. 25, 2014 - WSJ.com
Study: Tylenol in Pregnancy Linked to ADHD 7:56 a.m. Feb. 25, 2014 - InvestorPlace.com
The Ultimate Status Symbol: Freedom 5:56 a.m. Feb. 25, 2014 - GuruFocus.com
Colgate-Palmolive Operates In A Favorable Industry 5:49 a.m. Feb. 25, 2014 - Seeking Alpha
5 Biotech Stocks That Are Buyout Candidates 3:48 a.m. Feb. 25, 2014 - InvestorPlace.com
Pharmacyclics Attains 52-Week High - Analyst Blog 5:00 p.m. Feb. 24, 2014 - Zacks.com
Dow Today: Visa (V) Leads The Day Higher, Johnson & Johnson (JNJ) Lags 4:30 p.m. Feb. 24, 2014 - TheStreet.com
One Put, One Call Option To Know About For Johnson & Johnson 12:17 p.m. Feb. 24, 2014 - TheStreet.com
Voce Capital Responds to ConMed Board Changes 5:16 p.m. Feb. 27, 2014 - BusinessWire - BZX
Translational Regenerative Medicine: Market Prospects 2014-2024 11:35 a.m. Feb. 27, 2014 - PR Newswire - PRF
Dr. Martin Madaus to be Named Chairman and CEO of Ortho-Clinical Diagnostics (OCD) 11:00 a.m. Feb. 27, 2014 - BusinessWire - BZX
Biosense Webster Receives FDA Approval for First Catheter Ablation Therapy in the U.S. to Feature Direct Contact Force Technology for Treatment of Atrial Fibrillation 6:26 p.m. Feb. 25, 2014 - BusinessWire - BZX
Revlon Announces Executive Appointments 9:15 a.m. Feb. 25, 2014 - BusinessWire - BZX
Biosense Webster Receives FDA Approval for First Catheter Ablation Therapy in the U.S. to Feature Direct Contact Force Technology for Treatment of Atrial Fibrillation 9:02 a.m. Feb. 25, 2014 - BusinessWire - BZX
Johnson & Johnson to Participate in 2014 Cowen 34th Annual Health Care Conference 7:45 a.m. Feb. 25, 2014 - PR Newswire - PRF
Cordis Corporation Receives CE Mark for RENLANE™ Renal Denervation System to Treat Resistant Hypertension 9:59 a.m. Feb. 21, 2014 - BusinessWire - BZX
Jubilant Biosys Announces Expansion of Drug Discovery Alliance with Janssen Pharmaceutica 9:00 a.m. Feb. 19, 2014 - BusinessWire - BZX
Cordis Corporation Announces Exclusive Distribution Agreement with TriReme Medical, Inc. for the Chocolate® PTA Balloon Catheter 1:36 p.m. Feb. 18, 2014 - BusinessWire - BZX
Decision Diagnostics Announces Agreement for Funding of Its Prosecution of Anti-Trust and False Advertising Suits Against Division of Johnson & Johnson 11:25 a.m. Feb. 18, 2014 - Marketwire
BDO USA Honored with Work-Life Seal of Distinction for 2014 10:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
Two Ways to Invest in the Wireless Revolution 10:00 a.m. Feb. 18, 2014 - ACCESSWIRE
Global Laparoscopic Devices Industry 8:13 a.m. Feb. 18, 2014 - PR Newswire - PRF
Market Focus: Trends and Developments in the Skincare Sector in the US 9:00 a.m. Feb. 17, 2014 - PR Newswire - PRF
Decision Diagnostics Announces Agreement for the Funding of Its Prosecution of Anti-Trust and False Advertising Suits Against Division of Johnson & Johnson 3:30 p.m. Feb. 14, 2014 - Marketwire
Johnson & Johnson to Participate in 2014 Citi Global Health Care Conference 7:45 a.m. Feb. 14, 2014 - PR Newswire - PRF
Diabetes - KOL Insight and Consensus Outlook Modules 10:34 a.m. Feb. 13, 2014 - PR Newswire - PRF
China Spectacles Industry Report, 2013-2015 12:46 p.m. Feb. 12, 2014 - PR Newswire - PRF
Translational Regenerative Medicine: Market Prospects 2014-2024 10:11 a.m. Feb. 12, 2014 - PR Newswire - PRF
Billionaire Stan Druckenmiller's recent moves 11:50 a.m. Feb. 24, 2014 - Insider Monkey
You'd have to be a dope to buy marijuana stocks 1:36 p.m. Feb. 13, 2014 - blogs.marketwatch.com
FDA approval of leukemia treatment boosts shares of Pharmacyclics 1:57 p.m. Feb. 12, 2014 - blogs.marketwatch.com
Goldman: The 4 biggest themes of earnings season 8:06 a.m. Feb. 12, 2014 - blogs.marketwatch.com
10 stocks to beat a declining market 3:01 p.m. Feb. 7, 2014 - Mark Hulbert
Feds, pharma rivals team up on Alzheimer's 2:32 p.m. Feb. 6, 2014 - blogs.marketwatch.com
CVS move won’t slow e-cigarette sales 4:42 p.m. Feb. 5, 2014 - Jonnelle Marte
Newscast: Stocks mixed to start short week 6:32 p.m. Jan. 21, 2014 - MarketWatch
U.S. stocks close higher; earnings misses drag on Dow 4:51 p.m. Jan. 21, 2014 - Anora Mahmudova
Newscast: Stocks open week mixed 4:32 p.m. Jan. 21, 2014 - MarketWatch
Nasdaq nabs 13-year high, but Dow slips: stock market live blog recap 4:05 p.m. Jan. 21, 2014 - blogs.marketwatch.com
Ken Fisher's new top stock picks 2:48 p.m. Jan. 21, 2014 - Insider Monkey
Johnson & Johnson shares take a hit on full-year outlook 11:27 a.m. Jan. 21, 2014 - blogs.marketwatch.com
Newscast: Demand soars for humanely-raised pork 10:00 a.m. Jan. 21, 2014 - MarketWatch
Johnson & Johnson’s profit jumps 37% 9:49 a.m. Jan. 21, 2014 - Tess Stynes
Stock futures rise after China’s cash injections 9:32 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson sees 2014 EPS of $5.75 to $5.85 7:51 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 EPS excluding items $1.24 7:50 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 sales up 4.5% to $18.4B 7:49 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Johnson & Johnson Q4 EPS $1.23 vs. 91 cents 7:48 a.m. Jan. 21, 2014 - Barbara Kollmeyer
Why You Should Consider Guns, Germs And Steel For Your Portfolio 1:04 p.m. Feb. 27, 2014 - Seeking Alpha
Google's Plan For Your Body And Its Stock Split 12:05 p.m. Feb. 27, 2014 - Seeking Alpha
9 Dogs Of The Dow Seek 10% To 17% February Upsides 11:46 a.m. Feb. 27, 2014 - Seeking Alpha
Abbott Labs Has Fallen and It Can't Get Up 6:00 a.m. Feb. 27, 2014 - TheStreet.com
10-K: PHARMACYCLICS INC 5:15 p.m. Feb. 26, 2014 - Edgar Online - (EDG = 10Q, 10K)
Anika Arthritis Drug Approval Sends Stock Soaring 10:47 a.m. Feb. 26, 2014 - Investors Business Daily
Risk And Reward Analysis Of Apple's Stock 10:36 a.m. Feb. 26, 2014 - Seeking Alpha
Are High-Yield Equities Riskier Than Dividend Growth Stocks? 9:43 a.m. Feb. 26, 2014 - Seeking Alpha
Anika Arthritis Treatment Approval Brings All-Time Highs, Maybe More to Come 9:16 a.m. Feb. 26, 2014 - 247WallSt.com
3 Megacap Blue Chips You Don’t Want to Buy 7:47 a.m. Feb. 26, 2014 - InvestorPlace.com
Anika's Osteoarthritis Treatment Wins FDA Approval 5:45 p.m. Feb. 25, 2014 - WSJ.com
3 Dividend Stocks For Retirement 4:57 p.m. Feb. 25, 2014 - Seeking Alpha
Target's Valuation Largely Hits the Mark 4:12 p.m. Feb. 25, 2014 - WSJ.com
Study: Tylenol in Pregnancy Linked to ADHD 7:56 a.m. Feb. 25, 2014 - InvestorPlace.com
The Ultimate Status Symbol: Freedom 5:56 a.m. Feb. 25, 2014 - GuruFocus.com
Colgate-Palmolive Operates In A Favorable Industry 5:49 a.m. Feb. 25, 2014 - Seeking Alpha
5 Biotech Stocks That Are Buyout Candidates 3:48 a.m. Feb. 25, 2014 - InvestorPlace.com
Pharmacyclics Attains 52-Week High - Analyst Blog 5:00 p.m. Feb. 24, 2014 - Zacks.com
Dow Today: Visa (V) Leads The Day Higher, Johnson & Johnson (JNJ) Lags 4:30 p.m. Feb. 24, 2014 - TheStreet.com
One Put, One Call Option To Know About For Johnson & Johnson 12:17 p.m. Feb. 24, 2014 - TheStreet.com
Voce Capital Responds to ConMed Board Changes 5:16 p.m. Feb. 27, 2014 - BusinessWire - BZX
Translational Regenerative Medicine: Market Prospects 2014-2024 11:35 a.m. Feb. 27, 2014 - PR Newswire - PRF
Dr. Martin Madaus to be Named Chairman and CEO of Ortho-Clinical Diagnostics (OCD) 11:00 a.m. Feb. 27, 2014 - BusinessWire - BZX
Biosense Webster Receives FDA Approval for First Catheter Ablation Therapy in the U.S. to Feature Direct Contact Force Technology for Treatment of Atrial Fibrillation 6:26 p.m. Feb. 25, 2014 - BusinessWire - BZX
Revlon Announces Executive Appointments 9:15 a.m. Feb. 25, 2014 - BusinessWire - BZX
Biosense Webster Receives FDA Approval for First Catheter Ablation Therapy in the U.S. to Feature Direct Contact Force Technology for Treatment of Atrial Fibrillation 9:02 a.m. Feb. 25, 2014 - BusinessWire - BZX
Johnson & Johnson to Participate in 2014 Cowen 34th Annual Health Care Conference 7:45 a.m. Feb. 25, 2014 - PR Newswire - PRF
Cordis Corporation Receives CE Mark for RENLANE™ Renal Denervation System to Treat Resistant Hypertension 9:59 a.m. Feb. 21, 2014 - BusinessWire - BZX
Jubilant Biosys Announces Expansion of Drug Discovery Alliance with Janssen Pharmaceutica 9:00 a.m. Feb. 19, 2014 - BusinessWire - BZX
Cordis Corporation Announces Exclusive Distribution Agreement with TriReme Medical, Inc. for the Chocolate® PTA Balloon Catheter 1:36 p.m. Feb. 18, 2014 - BusinessWire - BZX
Decision Diagnostics Announces Agreement for Funding of Its Prosecution of Anti-Trust and False Advertising Suits Against Division of Johnson & Johnson 11:25 a.m. Feb. 18, 2014 - Marketwire
BDO USA Honored with Work-Life Seal of Distinction for 2014 10:00 a.m. Feb. 18, 2014 - BusinessWire - BZX
Two Ways to Invest in the Wireless Revolution 10:00 a.m. Feb. 18, 2014 - ACCESSWIRE
Global Laparoscopic Devices Industry 8:13 a.m. Feb. 18, 2014 - PR Newswire - PRF
Market Focus: Trends and Developments in the Skincare Sector in the US 9:00 a.m. Feb. 17, 2014 - PR Newswire - PRF
Decision Diagnostics Announces Agreement for the Funding of Its Prosecution of Anti-Trust and False Advertising Suits Against Division of Johnson & Johnson 3:30 p.m. Feb. 14, 2014 - Marketwire
Johnson & Johnson to Participate in 2014 Citi Global Health Care Conference 7:45 a.m. Feb. 14, 2014 - PR Newswire - PRF
Diabetes - KOL Insight and Consensus Outlook Modules 10:34 a.m. Feb. 13, 2014 - PR Newswire - PRF
China Spectacles Industry Report, 2013-2015 12:46 p.m. Feb. 12, 2014 - PR Newswire - PRF
Translational Regenerative Medicine: Market Prospects 2014-2024 10:11 a.m. Feb. 12, 2014 - PR Newswire - PRF
